H1’s Post

In recent years, it’s become increasingly important for #medicalaffairs teams to use data to build out business cases and to prove the value of the team’s efforts. Find out how Katie Shin uses H1 to find the right #HCPs and create the right strategies to forge an effective path forward for Sumitomo Pharma America, Inc.’s field medical execution. See how she was able to unify teams across the company: https://lnkd.in/giEeFK2K Learn more about HCP Universe here: https://hubs.la/Q02XV9Bv0 #sumitomo #smpa #HCPengagement #HCPdata #HCPeducation

It was a pleasure partnering with CallMiner and the fantastic group of industry experts (Kyle Carter and Eric Redline) in this webinar. Thanking Earl Feldman, Angelica Lunod and Scott Kendrick for the fantastic collaboration. The gist: Adverse Events (AEs) are an overhead and nightmare to administer for Pharmacovigilance (PV) teams - errors in detection, manual reviews that overwhelm their case processing teams, the constant back and forth between PV and patient supports teams etc. being a few challenges they continue to grapple with. AI, more specifically NLP, is an attractive proposition to solve the problem of AE signal detection and identification. Having said that, PV leaders should consider taking a step back and look at solving digitization more holistically across AE identification, validation, case processing and reporting. Feel free to register and watch the webinar recording!

The topic for this week’s The Kinetix Group-Powered by Petauri™ PACT Executive Briefing is, “Pharmacist Collaborative Practice Agreements (CPAs).” All 50 states now allow pharmacists and physicians to enter into Collaborative Practice Agreements (CPAs) in which one or more pharmacists establish a formal relationship with a prescriber, in which the prescriber can delegate specific tasks to a pharmacist under negotiated conditions, which would not otherwise be permitted under the pharmacist’s normal scope of practice Although state laws vary, generally, CPAs allow prescribers to delegate specific patient care tasks to pharmacists. The pharmacist’s scope of practice under a CPA is generally defined by established protocols that are condition or disease specific. For example, under a CPA, pharmacists may be empowered to perform patient assessments, order laboratory tests, prescribe drugs, counsel patients, and make referrals for related care. They may also be permitted to select, initiate, monitor, continue, discontinue, adjust, and refill ongoing therapy regimens. Expanding a pharmacist’s traditional scope of practice through CPAs may open up unique opportunities for life science companies to improve access to therapy, address health equity concerns, and allow for better care coordination among multiple care providers and in complex patient situations. Check out The Kinetix Group-Powered by Petauri™ growing library of TKG PACT Executive Briefings where you can listen and download the companion PDF infographics. https://lnkd.in/evZKhgre #Market_Access, #TKG, #TKGPACT, #Pharmacist_CPA, #Collaborative_Practice_Agreement, #Pharmacist, #Specialty_Pharmacy, #Pharmacy, #Medication

When a rapidly growing pharma company faced new competition, it turned to MMIT for its market access expertise. In this case study, learn how MMIT’s data and understanding of the nuances of payer policy and restriction data and segmenting the payer market helped the company make the best strategic decisions for each account. Download the case study: https://ow.ly/vC1X50R7ZHT. #PatientAccess #HealthcareData #HealthcareInsights #MarketAccess

When a rapidly growing pharma company faced new competition, it turned to MMIT for its market access expertise. In this case study, learn how MMIT’s data and understanding of the nuances of payer policy and restriction data and segmenting the payer market helped the company make the best strategic decisions for each account. Download the case study: https://ow.ly/vC1X50R7ZHT. #PatientAccess #HealthcareData #HealthcareInsights #MarketAccess

When a rapidly growing pharma company faced new competition, it turned to MMIT for its market access expertise. In this case study, learn how MMIT’s data and understanding of the nuances of payer policy and restriction data and segmenting the payer market helped the company make the best strategic decisions for each account. Download the case study: https://ow.ly/vC1X50R7ZHT. #PatientAccess #HealthcareData #HealthcareInsights #MarketAccess

🚀 Join Myonex for an upcoming webinar on clinical supply chain management! Explore the challenges faced by the clinical supply chain, from navigating complex trial designs to ensuring sustainability and cost control! The expert speaker, Benedict Hirth, will illuminate the risks associated with a poorly managed clinical supply chain, such as delayed drug availability, aggressive enrollment targets, and potential commercialization delays. Learn how drug shortages can impact reputation, burden patients, and affect treatment efficacy and retention, including insights into proactive strategies for risk identification, market observation, and scenario preparedness. 💡 REGISTER HERE: https://buff.ly/3Wq49Bj

When a rapidly growing pharma company faced new competition, it turned to MMIT for its market access expertise. “The questions we ask may be different as the situation changes, but we’ll keep looking to MMIT for its collective horsepower and knowledge.” In this case study, learn how MMIT’s data and understanding of the nuances of payer policy and restriction data and segmenting the payer market helped the company make the best strategic decisions for each account. Read the case study: https://ow.ly/41wm50SbgWI. #PatientAccess #HealthcareData #HealthcareInsights #MarketAccess

Work and Data Flow is a key topic within #DataManagement. Data Integration with API is standard for most Tech Vendors nowadays, but Data and Information has to flow in all directions. Including Metadata, Queries and audit trail information. Join the 🔥 topic with Frank Jensen from innovation key player Novo Nordisk provided by the ACDM: Association for Clinical Data Management

Confirmed Interview Session! 🙌 Beth Loudon, Head of Market Access, BIVDA Interview Session - Unlocking Innovation and Value in Diagnostics: A Fireside Chat with Beth Loudon on MES Procurement In this intimate fireside chat, Beth Loudon, Head of Market Access at the British In Vitro Diagnostics Association (BIVDA), will share her expertise on navigating the Managed Equipment Service (MES) procurement model in the diagnostics industry. The MES approach has become an innovative solution for healthcare providers, offering a sustainable alternative to traditional procurement by focusing on comprehensive, long-term equipment management solutions rather than outright purchases. Are you a senior NHS leader in Clinical Diagnostics & Medical Sciences? Register for a complimentary delegate pass here👇 https://loom.ly/iOKg9w8